Skip to content
News
Data
Podcast
Clinics
EVENTS
News
Data
Podcast
Clinics
EVENTS
Search
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
Advertise
NEWSLETTER
News
Data
Podcast
Clinics
EVENTS
News
Data
Podcast
Clinics
EVENTS
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
About
Contact
About
Contact
Advertise
nEWSLETTER
Search
Search
Cala launches nationwide kI...
Resolution Therapeutics to ...
Genentech, Alector partner ...
Coya Therapeutics completes...
Alterity’s Parkinson’s drug...
Cala launches nationwide kI...
Resolution Therapeutics to ...
Genentech, Alector partner ...
Coya Therapeutics completes...
Alterity’s Parkinson’s drug...
Latest Articles
Ecosystem
Longevity investors put evidence to the test
Biotech
Longevica turns 16k mice into a health-and-lifespan drug pipeline
Ecosystem
Reflections from ARDD 2026
AI/Digital
UCLA lands $25m to test dementia AI tools
Ecosystem
NUS takes longevity science into the boardroom
Biotech
China’s longevity biotech head start
AI/Digital
Why the future of skin longevity belongs to generative bio-platforms
Ecosystem
‘Show me the error bars before you sell me longevity’
Diagnostics
Mito adds a $249 heart scan. Who needs one?
Lt Wire
Cala launches nationwide kIQ Plus wearable for hand tremor
Resolution Therapeutics to present interim liver disease therapy data at AASLD
Genentech, Alector partner on $1.2b Parkinson’s drug deal
Coya Therapeutics completes enrollment in ALSTARS ALS trial
Alterity’s Parkinson’s drug trial shows slowed clinical decline, advances to Phase 3
Genflow presents interim results from aging-dog SIRT6c study
BodySpec opens body composition scanning storefront in downtown Oakland
Your daily longevity briefing
The latest longevity science, investment, innovation and insights-delivered every morning.
Email Address
(Required)
Contact Source
Investment
Longevity investors put evidence to the test
UCLA lands $25m to test dementia AI tools
China’s longevity biotech head start
‘Show me the error bars before you sell me longevity’
Immorta Bio picked for NYU Stern startup program
The exit math forcing an M&A decade
Junevity takes gene-network reset into skincare
Longevity biotech’s $173 billion in waiting
Biotech
Longevica turns 16k mice into a health-and-lifespan drug pipeline
China’s longevity biotech head start
Immorta Bio picked for NYU Stern startup program
FDA approves new kind of Parkinson’s pill from AbbVie
REGENXBIO’s diabetic eye gene therapy reaches three-year mark
Lilly and Novo share GLP-1 longevity data
The future of peptide medicine is about closing the gray market
Annovis turns to AI to fast-track its Alzheimer’s filing
Research
Genflow gene therapy nudges aging clock in dogs
Basecamp raises $140m to teach AI all of biology
Johns Hopkins team wins $1m XPRIZE for immune aging research
Serina’s new Parkinson’s therapy clears first safety hurdle
AI/tech diagnostics
Brain health ‘collaboratory’ focuses on non-invasive Alzheimer’s therapy
Perplexity enters the consumer health AI arena
Startup targets ‘untreatable blindness’ with bionic eye system
Science Corp lands $230m to commercialize vision restoration chip
Supplements
When supplements don’t make it past the gut
Elivity brings spray-based supplements to Asia
PhytoGaia puts palm fruit at the heart of healthy aging
Can we prime skin to regenerate better?
Ecosystem
Longevity investors put evidence to the test
NUS takes longevity science into the boardroom
‘Show me the error bars before you sell me longevity’
The future of peptide medicine is about closing the gray market
The latest longevity science, investment, innovation and insight, delivered every morning.
First Name
(Required)
Email Address
(Required)
Contact Source
Unlock Longevity Biotech Report for FREE
$617BN - Annual global revenue by 2045
$30BN+ - Invested in under 2 years
3,036 - Therapeutics individually assessed
Access full report